Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
21 März 2024 - 11:35AM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, today announced it will report fourth quarter and full
year 2023 financial results before the market opens
on Thursday, March 28, 2024. Following the release, the
Company will host a live conference call and webcast at 8:30
a.m. ET to discuss the Company’s financial results and provide
a business update.
Event |
Agile Therapeutics Fourth
Quarter & Full Year 2023 Financial Results Conference Call |
Date |
Thursday, March 28, 2024 |
Time |
8:30 a.m. ET / 5:30 a.m.
PT |
A live webcast of the conference call may be accessed via the
Investor Relations portion of the Agile Therapeutics website
at https://ir.agiletherapeutics.com/events-and-presentations.
To participate in the live conference call via telephone, please
register here. Upon registering, a dial-in number and unique
PIN will be provided to join the conference call.
About Agile
Therapeutics, Inc.Agile
Therapeutics is a women's healthcare company dedicated to
fulfilling the unmet health needs of today’s women. Our product and
product candidates are designed to provide women with contraceptive
options that offer freedom from taking a daily pill, without
committing to a longer-acting method. Our initial product, Twirla®,
(levonorgestrel and ethinyl estradiol) transdermal system, is a
non-daily prescription contraceptive. Twirla is based on our
proprietary transdermal patch technology, called Skinfusion®, which
is designed to allow drug delivery through the skin. For more
information, please visit the company website at
www.agiletherapeutics.com. The Company may
occasionally disseminate material, nonpublic information on the
Company’s website and LinkedIn account.
Contact:Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024